Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Issue 8 (4th June 2019)
- Record Type:
- Journal Article
- Title:
- Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Issue 8 (4th June 2019)
- Main Title:
- Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy
- Authors:
- Magers, Martin J
Kaimakliotis, Hristos Z
Barboza, Marcelo P
Bandali, Elhaam
Adra, Nabil
Koch, Michael O
Cheng, Liang - Abstract:
- Abstract : Aims: To describe a large tertiary care academic centre's experience with patients who achieve a complete pathological response (ie, ypT0N0) following neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) with emphasis on morphological features present in the RC and clinical outcome. Methods: 41 patients with ypT0N0 disease following transurethral resection of bladder tumour (TURBT), NAC and RC with available clinical follow-up information were analysed. Slides from all RCs were reviewed to confirm pathological stage and assess for morphological parameters (eg, foreign body giant cell reaction, dystrophic calcification, scar and fat necrosis). Results: With median follow-up of 32.8 months, the recurrence-free survival at 1 and 5 years was 97.4% and 93.5%, while the overall survival at 3 and 5 years was 94.2% and 88.6%, respectively. No patients died of urothelial carcinoma. Stage assigned at TURBT was 1 pTa (2%), 1 pT1 (2%), 38 pT2 (93%) and 1 pT3a (2%). 17 TURBTs demonstrated variant histology, with the majority of these being squamous (65%). The most common morphological features present at RC were scar (100%), foreign body giant cell reaction (80%), chronic inflammation within lamina propria (68%) and dystrophic calcifications (39%). Other morphological features were less common or absent. Conclusion: ypT0N0 disease at RC portends an excellent prognosis, regardless of stage or variant histology in the TURBT; scar, foreign body giant cell reaction, chronicAbstract : Aims: To describe a large tertiary care academic centre's experience with patients who achieve a complete pathological response (ie, ypT0N0) following neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) with emphasis on morphological features present in the RC and clinical outcome. Methods: 41 patients with ypT0N0 disease following transurethral resection of bladder tumour (TURBT), NAC and RC with available clinical follow-up information were analysed. Slides from all RCs were reviewed to confirm pathological stage and assess for morphological parameters (eg, foreign body giant cell reaction, dystrophic calcification, scar and fat necrosis). Results: With median follow-up of 32.8 months, the recurrence-free survival at 1 and 5 years was 97.4% and 93.5%, while the overall survival at 3 and 5 years was 94.2% and 88.6%, respectively. No patients died of urothelial carcinoma. Stage assigned at TURBT was 1 pTa (2%), 1 pT1 (2%), 38 pT2 (93%) and 1 pT3a (2%). 17 TURBTs demonstrated variant histology, with the majority of these being squamous (65%). The most common morphological features present at RC were scar (100%), foreign body giant cell reaction (80%), chronic inflammation within lamina propria (68%) and dystrophic calcifications (39%). Other morphological features were less common or absent. Conclusion: ypT0N0 disease at RC portends an excellent prognosis, regardless of stage or variant histology in the TURBT; scar, foreign body giant cell reaction, chronic inflammation and dystrophic calcifications are often present. … (more)
- Is Part Of:
- Journal of clinical pathology. Volume 72:Issue 8(2019)
- Journal:
- Journal of clinical pathology
- Issue:
- Volume 72:Issue 8(2019)
- Issue Display:
- Volume 72, Issue 8 (2019)
- Year:
- 2019
- Volume:
- 72
- Issue:
- 8
- Issue Sort Value:
- 2019-0072-0008-0000
- Page Start:
- 550
- Page End:
- 553
- Publication Date:
- 2019-06-04
- Subjects:
- bladder -- urothelial carcinoma -- staging -- histopathology -- neoadjuvant chemotherapy -- prognosis
Pathology -- Periodicals
Pathology, Molecular -- Periodicals
616.0705 - Journal URLs:
- http://jcp.bmjjournals.com ↗
http://jcp.bmjjournals.com/content/by/year ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=162&action=archive ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/jclinpath-2019-205742 ↗
- Languages:
- English
- ISSNs:
- 0021-9746
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17916.xml